Analysis of vitamin D metabolism gene expression in human bone: Evidence for autocrine control of bone remodelling

Journal of Steroid Biochemistry and Molecular Biology

Volumn 144, Issue PART A, 2014, Pages 110-113

  Ormsby, Renee T ^a   Findlay, David M ^a   Kogawa, Masakazu ^a   Anderson, Paul H ^b   Morris, Howard A ^b   Atkins, Gerald J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Autocrine; Bone; Bone remodelling; CYP27B1; Osteocyte; Osterix; Runx2; Vitamin D

Indexed keywords

CALCITRIOL; COLONY STIMULATING FACTOR 1; CYTOCHROME P450; CYTOCHROME P450 27B1; DENTIN MATRIX PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 8; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BONE CELL; BONE REMODELING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MARKER GENE; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; OSTEOLYSIS; PARACRINE SIGNALING; PROTEIN EXPRESSION; TRABECULAR BONE; VITAMIN D METABOLISM; BONE; BRIL GENE; CA2 GENE; CATK GENE; CELL LINEAGE; COL1A1 GENE; COLONY STIMULATING FACTOR 1 GENE; CYP24A1 GENE; CYP27B1 GENE; DMP1 GENE; FGF23 GENE; GENE; HIF1A GENE; INTERLEUKIN 8 GENE; MEPE GENE; NFATC1 GENE; OCN GENE; OPG GENE; OSTEOCLAST DIFFERENTIATION FACTOR GENE; OSX GENE; PHEX GENE; PROTEIN FUNCTION; REVIEW; SOST GENE; TNAP GENE; TRANSCRIPTION FACTOR MSX2 GENE; TRANSCRIPTION FACTOR RUNX2 GENE; TRAP GENE; TWEAK GENE; VITAMIN D RECEPTOR GENE;

AUTOCRINE; BONE; BONE REMODELLING; CYP27B1; OSTEOCYTE; OSTERIX; RUNX2; VITAMIN D;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; AUTOCRINE COMMUNICATION; BONE AND BONES; BONE REMODELING; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; VITAMIN D;

EID: 84906791647     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.09.016     Document Type: Review

References (29)

1. P.H. Anderson, and G.J. Atkins The skeleton as an intracrine organ for vitamin D metabolism Mol. Aspects Med. 29 6 2008 397 406
2. P.H. Anderson, G.J. Atkins, A.G. Turner, M. Kogawa, D.M. Findlay, and H.A. Morris Vitamin D metabolism within bone cells: effects on bone structure and strength Mol. Cell. Endocrinol. 347 1-2 2011 42 47
3. G.J. Atkins, P.H. Anderson, D.M. Findlay, K.J. Welldon, C. Vincent, A.C. Zannettino, D. O'Loughlin, and P.H.A. Morris Metabolism of vitamin D(3) in human osteoblasts: evidence for autocrine and paracrine activities of 1alpha,25-dihydroxyvitamin D(3) Bone 40 6 2007 1517 1528
4. O. Dardenne, J. Prud'homme, A. Arabian, F.H. Glorieux, and R. St-Arnaud Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets Endocrinology 142 7 2001 3135 3141
5. D.K. Panda, D. Miao, M.L. Tremblay, J. Sirois, R. Farookhi, G.N. Hendy, and D. Goltzman Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction Proc. Natl. Acad. Sci. USA 98 13 2001 7498 7503
6. M. Kogawa, P.H. Anderson, D.M. Findlay, H.A. Morris, and G.J. Atkins The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts J. Steroid Biochem. Mol. Biol. 121 1-2 2010 277 280
7. M. Kogawa, D.M. Findlay, P.H. Anderson, R. Ormsby, C. Vincent, H.A. Morris, and G.J. Atkins Osteoclastic metabolism of 25(OH)-vitamin D3: A potential mechanism for optimization of bone resorption Endocrinology 151 10 2010 4613 4625
8. P.H. Anderson, P.D. O'Loughlin, B.K. May, and H.A. Morris Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels Bone 36 4 2005 654 662
9. G.J. Atkins, K.J. Welldon, C.A. Holding, D.R. Haynes, D.W. Howie, and D.M. Findlay The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles Biomaterials 30 22 2009 3672 3681
10. G.J. Atkins, P.S. Rowe, H.P. Lim, K.J. Welldon, R. Ormsby, A.R. Wijenayaka, L. Zelenchuk, A. Evdokiou, and D.M. Findlay Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism J. Bone Miner. Res. 26 7 2011 1425 1436
11. N.L. Fazzalari, J.S. Kuliwaba, G.J. Atkins, M.R. Forwood, and D.M. Findlay The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis J. Bone Miner. Res. 16 6 2001 1015 1027
12. H. Tsangari, D.M. Findlay, J.S. Kuliwaba, G.J. Atkins, and N.L. Fazzalari Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck Bone 35 1 2004 334 342
13. Y.J. Kim, H.N. Kim, E.K. Park, B.H. Lee, H.M. Ryoo, S.Y. Kim, I.S. Kim, J.L. Stein, J.B. Lian, G.S. Stein, A.J. van Wijnen, and J.Y. Choi The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells Gene 366 1 2006 145 151
14. Q. Tu, P. Valverde, and J. Chen Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells Biochem. Biophys. Res. Commun. 341 4 2006 1257 1265
15. T. Komori Regulation of osteoblast differentiation by Runx2 Adv. Exp. Med. Biol. 658 2010 43 49
16. C. Zhang, W. Tang, Y. Li, F. Yang, D.R. Dowd, and P.N. MacDonald Osteoblast-specific transcription factor Osterix increases vitamin D receptor gene expression in osteoblasts PLoS ONE 6 10 2011 e26504
17. K. Nakashima, X. Zhou, G. Kunkel, Z. Zhang, J.M. Deng, R.R. Behringer, and B. de Crombrugghe The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation Cell 108 1 2002 17 29
18. Y. Nishio, Y. Dong, M. Paris, R.J. O'Keefe, E.M. Schwarz, and H. Drissi Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene Gene 372 2006 62 70
19. K. Shirakabe, K. Terasawa, K. Miyama, H. Shibuya, and E. Nishida Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5 Genes Cells 6 10 2001 851 856
20. H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E.F. Wagner, T.W. Mak, T. Kodama, and T. Taniguchi Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev. Cell 3 6 2002 889 901
21. D.K. Panda, D. Miao, I. Bolivar, J. Li, R. Huo, G.N. Hendy, and D. Goltzman Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis J. Biol. Chem. 279 16 2004 16754 16766
22. M.M. Winslow, M. Pan, M. Starbuck, E.M. Gallo, L. Deng, G. Karsenty, and G.R. Crabtree Calcineurin/NFAT signaling in osteoblasts regulates bone mass Dev. Cell 10 6 2006 771 782
23. M. Kogawa, A.R. Wijenayaka, R. Ormsby, G.P. Thomas, P.H. Anderson, L.F. Bonewald, D.M. Findlay, and G.J. Atkins Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2 J. Bone Miner. Res. 2013 10.1002/jbmr.2003 (in press)
24. L.H. Shapiro, P.J. Venta, Y.-S.L. Yu, and R.E. Tashian Carbonic anhydrase II is induced in HL-60 cells by 1,25-dihydroxyvitamin D3: A model for osteoclast gene regulation FEBS Lett. 249 2 1989 307 310
25. G.J. Atkins, P.H. Anderson, D.M. Findlay, and H.A. Morris D. Feldman, Target Genes: Bone Proteins, Vitamin D 3rd ed. 2011 Elsevier Academic Press San Diego, CA
26. P. Moffatt, M.H. Gaumond, P. Salois, K. Sellin, M.C. Bessette, E. Godin, P. Tambasco de Oliveira, G.J. Atkins, A. Nanci, and G. Thomas Bril: A novel bone-specific modulator of mineralization J. Bone Miner. Res. 23 9 2008 1497 1508
27. P. Lechler, S.M. Klein, L. Prantl, C. Englert, T. Renkawitz, and J. Grifka Hypoxic downregulation of cellular proliferation and loss of phenotype stability in human osteoblasts is mediated by HIF-1alpha Clin. Hemorheol. Microcirc. 49 1-4 2011 279 286
28. H.J. Knowles, and N.A. Athanasou Acute hypoxia and osteoclast activity: A balance between enhanced resorption and increased apoptosis J. Pathol. 218 2 2009 256 264
29. B. Hopwood, A. Tyskin, D. Findlay, and N. Fazzalari Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-B/bone morphogenetic protein signalling Arthritis Res. Ther. 9 5 2007 1 21